Company Analysis LifeTech Scientific Corporation
1. Summary
Advantages
- Current debt level 0.2065% is below 100% and has decreased over 5 years from 18.64%.
- The company's current efficiency (ROE=8.4%) is higher than the sector average (ROE=5.19%)
Disadvantages
- Price (1.44 HK$) is higher than fair price (0.7302 HK$)
- Dividends (0%) are below the sector average (5.7%).
- The stock's return over the last year (-38.07%) is lower than the sector average (-27.85%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| LifeTech Scientific Corporation | Healthcare | Index | |
|---|---|---|---|
| 7 days | -6.3% | -2.4% | -1.8% |
| 90 days | -26.6% | -29.8% | -5.9% |
| 1 year | -38.1% | -27.8% | 18.3% |
1302 vs Sector: LifeTech Scientific Corporation has significantly underperformed the "Healthcare" sector by -10.23% over the past year.
1302 vs Market: LifeTech Scientific Corporation has significantly underperformed the market by -56.35% over the past year.
Stable price: 1302 is not significantly more volatile than the rest of the market on "Hong Kong Exchanges" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 1302 with weekly volatility of -0.7322% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (1.44 HK$) is higher than the fair price (0.7302 HK$).
Price is higher than fair: The current price (1.44 HK$) is 49.3% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (34.87) is lower than that of the sector as a whole (35.42).
P/E vs Market: The company's P/E (34.87) is higher than that of the market as a whole (26.67).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.76) is lower than that of the sector as a whole (3.68).
P/BV vs Market: The company's P/BV (2.76) is higher than that of the market as a whole (-11.94).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (7.24) is lower than that of the sector as a whole (7.59).
P/S vs Market: The company's P/S indicator (7.24) is higher than that of the market as a whole (2.77).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (24.38) is higher than that of the sector as a whole (2.91).
EV/Ebitda vs Market: The company's EV/Ebitda (24.38) is higher than that of the market as a whole (9.94).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 4.36% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (4.36%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (50.73%).
5.4. ROE
ROE vs Sector: The company's ROE (8.4%) is higher than that of the sector as a whole (5.19%).
ROE vs Market: The company's ROE (8.4%) is higher than that of the market as a whole (6.3%).
5.5. ROA
ROA vs Sector: The company's ROA (6.28%) is higher than that of the sector as a whole (3.47%).
ROA vs Market: The company's ROA (6.28%) is higher than that of the market as a whole (3.39%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '5.7%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
